ABSTRACT
Background:Ketamine either alone or as an adjuvant is associated with an acute reduction in the severity of depression, while its effect on cognitive profile is is equivocal.
Objectives: This study compared the mood-elevating and cognitive outcomes of ketamine in combination with propofol versus propofol alone as anaesthetic agents in ECT.
Methods: In this randomised-controlled study, 70 patients, aged 18-65years, undergoing ECT for DSM-V major depressive disorder were randomised into two groups. The ketamine-propofol group received intravenous propofol 0.6mg/kg and ketamine 0.6mg/kg, while the second group received intravenous propofol 1.2mg/kg only. Hamilton Depression Rating Scale (HAM-D) was used to assess the severity of depression, the Mini-Mental State Examination (MMSE) was used to assess cognitive performance, pre-ECT (T1), post-1st ECT (T2) and post-3rd ECT
course (T3). The Analysis of Covariance and the mixed model linear regression were used to analyse the effect of the intervention. Analyses were by SPSS at 95% CI, p < 0.05.
Results: There was a significant reduction in HAM-D score post-3rd ECT in the ketamine-propofol group versus propofol group, F (1,58) = 23.24, p = 0.000, = 0.286. There was no significant group difference on post-ECT course HAM-D score, F (1) = 0.004, p = 0.9. There was no significant group difference on post-ECT course MMSE scores, F (1) = 2.3, p = 0.1. There was no significant group difference on post-3rd ECT MMSE score, F (1,56) = 0.382, P = 0.5, 5Øß2 = 0.007, no significant group difference on post-ECT course MMSE scores, (F(1) = 2.3, p = 0.1.
Conclusion: Ketamine-propofol anaesthesia in ECT is associated with temporary improvement of depressive symptoms, without any superiority to propofol in cognitive outcome at any level of ECT treatment.
Keywords: Ketamine-propofol combination, Propofol, ECT, Cognitive-impairment, Major depression.